To the best of our knowledge, RUNX1 expression and activity on retinal and lacrimal gland development and function have never been studied in the context of Trisomy 21, a topic that should be taken in consideration toward designing better diagnostic and therapeutic innovations for ophthalmologic alterations of Down syndrome individuals. Here, RUNX1 is linked to Down syndrome.